Author:
Davlantes Elizabeth,Jorba Jaume,Henderson Elizabeth,Bullard Kelley,Deka Mark. A.,Kfutwah Anfumbom,Martin Javier,Bessaud Maël,Shulman Lester M.,Hawes Kaija,Diop Ousmane M.,Bandyopadhyay Ananda S.,Zipursky Simona,Burns Cara C.
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference5 articles.
1. Engineering the live-attenuated polio vaccine to prevent reversion to virulence.;Yeh;Cell Host Microbe,2020
2. Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under Emergency Use Listing—worldwide, March–October 2021.;Martin;MMWR Morb Mortal Wkly Rep,2022
3. Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial.;Zaman;Lancet,2023
4. A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story.;Bandyopadhyay;Lancet Infect Dis,2023
5. Preventing vaccine-derived poliovirus emergence during the polio endgame.;Pons-Salort;PLoS Pathog,2016
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献